NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Survivorship

The Role of Bioimpedance Spectroscopy (BIS) in the Care of Breast Cancer Patients and Survivors: Best Practices Today and Future Research in Therapy

Featured Faculty
Nicole L. Stout, DPT, CLT-LANA, FAPTA, Research Assistant Professor, Associate Director Survivorship Program, West
Virginia University Cancer Institute
Maureen McBeth, MPT, CLT-LANA, Key Accounts Specialist, ImpediMed



Join our experts! Nicole Stout, DPT, CLT-LANA, FAPTA, a pioneer in prospective surveillance and early intervention for breast
cancer-related lymphedema, and Maureen McBeth, MPT, CLT-LANA discuss evidence, protocols, and implementation best practices.
Hear their expert perspectives on the role of bioimpedance spectroscopy (BIS) technology as well as the latest trends and future research
in therapy for breast cancer patients.

Learning Objectives

  • Understand the evidence and protocols for prospective surveillance
  • Learn the techniques and best practices to bring BIS into your practice
  • Hear about the latest trends and future research in therapy for breast cancer patients


Featured Faculty

Nicole L. Stout DPT, CLT-LANA, FAPTA

Nicole L. Stout DPT, CLT-LANA, FAPTA

Research Assistant Professor, Associate Director Survivorship Program, West Virginia University Cancer Institute

Dr. Nicole L. Stout is a research assistant professor in the School of Medicine, Department of Hematology/Oncology at West Virginia University Cancer Institute and with the School of Public Health, Department of Health Policy, Management, and Leadership. She also serves as the Associate Director of the WVU Cancer Institute’s Survivorship Program where she coordinates the survivorship research agenda and supportive care infrastructure development between the cancer center and community. Dr. Stout’s research focuses on the implementation of prospective, risk stratified functional assessment and symptom management strategies in cancer care delivery and studying community outreach and engagement strategies with rural primary care providers to enable community-based survivorship care. Dr. Stout is the co-chair of the Alliance Clinical Trials Network, Rural Health Working Group, a steering committee member with the Appalachian Community Cancer Alliance, and serves on the board of directors for the West Virginia Oncology Society.

Dr. Stout is an internationally recognized expert and leader in the field of cancer rehabilitation and survivorship care. Her work and research have been foundational to developing the prospective surveillance model for morbidity management in cancer care. She has given over 300 lectures nationally and internationally, authored and co-authored over 90 peer-review and invited publications, several book chapters, and is the co-author of the book 100 Questions and Answers about Lymphedema.

Maureen McBeth, MPT, CLT-LANA

Maureen McBeth, MPT, CLT-LANA

Key Accounts Specialist, ImpediMed

Maureen has over 25 years’ experience as a physical therapist, specializing in lymphedema and cancer rehabilitation. She is a member of APTA and the Lymphatic Disorders Special Interest Group of the Academy of Oncologic Physical Therapy. She regularly speaks at conferences and continuing education programs, has been involved in a long-term volunteer project to help advance lymphedema care in Cali, Colombia, and supports the many lymphatic advocacy efforts in the US. Her passion is geared toward creating the knowledge base and driving the social connections to increase the adoption of new technology and clinical practice guidelines for prospective surveillance of cancer-related lymphedema.

SOZO Device with L-Dex

Learn More About SOZO®

SOZO uses ImpediMed’s BIS technology to measure and track critical information about the human body to aid clinicians in managing chronic disease and maximizing patient health. SOZO is non-invasive, fast, and easy to use. Results from the 30-second test* are available immediately providing proactive patient care including early detection of disease progression, treatment monitoring, and patient education.

*As tested on Android

Contact Us